Market Research Logo

Actelion Pharmaceuticals Ltd - Strategic SWOT Analysis Review

Actelion Pharmaceuticals Ltd - Strategic SWOT Analysis Review

- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Actelion Pharmaceuticals Ltd (Actelion), subsidiary of Johnson & Johnson is a biopharmaceutical company, which discovers, develops and commercializes innovative treatments for diseases with considerable unmet medical needs. The company focuses on the development of treatments for pulmonary arterial hypertension (PAH). Its PAH franchise products include Tracleer (bosentan), Opsumit (macitentan), Veletri (epoprostenol for injection), Ventavis (iloprost) and Uptravi (selexipag). Its specialty product includes Zavesca (miglustat). Actelion also offers approved treatments for diseases including Type 1 Gaucher disease, Niemann-Pick type C disease and digital ulcers in patients with systemic sclerosis. The company offers its products in various countries across Europe, besides Japan, China, Russia, Mexico and the US. Actelion is headquartered in Allschwil, Switzerland.

Actelion Pharmaceuticals Ltd Key Recent Developments

May 21,2019: Owlstone Medical and Actelion to develop breath test for PH
Aug 06,2018: Alzheon appoints former IVAX president, Neil Flanzraich, JD, as vice chairman of board of directors

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.


Section 1 - About the Company
Actelion Pharmaceuticals Ltd - Key Facts
Actelion Pharmaceuticals Ltd - Key Employees
Actelion Pharmaceuticals Ltd - Key Employee Biographies
Actelion Pharmaceuticals Ltd - Major Products and Services
Actelion Pharmaceuticals Ltd - History
Actelion Pharmaceuticals Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Actelion Pharmaceuticals Ltd - Business Description
Actelion Pharmaceuticals Ltd - SWOT Analysis
SWOT Analysis - Overview
Actelion Pharmaceuticals Ltd - Strengths
Actelion Pharmaceuticals Ltd - Weaknesses
Actelion Pharmaceuticals Ltd - Opportunities
Actelion Pharmaceuticals Ltd - Threats
Actelion Pharmaceuticals Ltd - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Actelion Pharmaceuticals Ltd, Recent Deals Summary
Section 4 – Company’s Recent Developments
May 21, 2019: Owlstone Medical and Actelion to develop breath test for PH
Aug 06, 2018: Alzheon appoints former IVAX president, Neil Flanzraich, JD, as vice chairman of board of directors
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Actelion Pharmaceuticals Ltd, Key Facts
Actelion Pharmaceuticals Ltd, Key Employees
Actelion Pharmaceuticals Ltd, Key Employee Biographies
Actelion Pharmaceuticals Ltd, Major Products and Services
Actelion Pharmaceuticals Ltd, History
Actelion Pharmaceuticals Ltd, Subsidiaries
Actelion Pharmaceuticals Ltd, Key Competitors
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Actelion Pharmaceuticals Ltd, Recent Deals Summary
List of Figures
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report